The cationic nanoliposomes loaded with asymmetric PCR product targeting PTK6 mRNA and induce apoptosis in PANC-1 cells
Reyhane Fooladi Vayqan, Maliheh Entezari, Raziye Tajali, Neda Zali, Ali Jebali, Amir Sadeghi, Mehrdad Hashemi · 2026
Read The cationic nanoliposomes loaded with asymmetric PCR product targeting PTK6 mRNA and induce apoptosis in PANC-1 cells by Reyhane Fooladi Vayqan, Maliheh Entezari, Raziye Tajali, Neda Zali, Ali Jebali, Amir Sadeghi, Mehrdad Hashemi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13454255.txt.
Description
Reyhane Fooladi Vayqan and others tested fat-bubble carriers in 2026 to kill pancreatic cancer cells by silencing a survival gene. Protein tyrosine kinase 6, known as PTK6, helps tumour cells stay alive and is a drug target in pancreatic cancer. The team built cationic nanoliposomes loaded with an asymmetric PCR product that targets PTK6 messenger RNA.
An antisense single-stranded DNA matching the PTK6 code was made by asymmetric PCR, cleaned, and packed into positively charged nanoliposomes. The carriers were near-spherical, roughly thirty to one hundred twenty nanometres across, with a positive surface charge. In dish tests, they cut viability in PANC-1 cancer cells, spurred cell death, and lowered PTK6 protein levels, with less harm to non-cancer pancreatic cells. The work offers a targeted delivery route for pancreatic cancer therapy.
Catalog record
| CREATOR | Reyhane Fooladi Vayqan, Maliheh Entezari, Raziye Tajali, Neda Zali, Ali Jebali, Amir Sadeghi, Mehrdad Hashemi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |